Nalpas B, Driss F, Pol S, Hamelin B, Housset C, Brechot C, Berthelot P
Liver Unit, Hospital Laënnec, Paris, France.
J Hepatol. 1991 Jan;12(1):70-4. doi: 10.1016/0168-8278(91)90912-u.
We conducted a retrospective study in 229 patients to determine the prevalence of hepatitis C virus (HCV) according to the type of liver disease and also the serum hepatitis B virus (HBV) status. There were 55 cases of hepatocellular carcinoma (HCC), 78 cases of alcoholic cirrhosis (AC) and 96 cases of non-cirrhotic alcohol liver disease (NCA). Half the AC and NCA groups were constituted of patients with or without serum HBV markers. The prevalence of anti-HCV antibodies in HCC (58.2%) was significantly higher than in the other groups (AC, 35.9%; NCA, 17.7%). Combining the two AC and NCA groups gave a 25.8% anti-HCV prevalence in the alcoholics. Altogether anti-HCV antibodies were more frequently present in HBV-positive than in HBV-negative patients (42.2 vs. 26.1%, p less than 0.01), although the difference was not significant when the HCC group was separately analysed. The S/N ratio of anti-HCV-positive samples varied according to the type of the disease (tumorous vs. non-tumorous) and to the serum HBV status. Indeed, 65.6% of HCC had a S/N greater than 4 compared to only 32.2 and 23.5% in AC and NCA, respectively (p less than 0.01). On the other hand more than half of the AC and NCA had a S/N less than 2, indicating possible artefacts in certain cases. The 15 HBsAg and anti-HCV-positive patients had a significantly lower mean S/N than patients displaying only antibodies against HBV, even in the HCC group.(ABSTRACT TRUNCATED AT 250 WORDS)
我们对229例患者进行了一项回顾性研究,以根据肝病类型及血清乙肝病毒(HBV)状态确定丙型肝炎病毒(HCV)的流行情况。其中有55例肝细胞癌(HCC)患者、78例酒精性肝硬化(AC)患者和96例非肝硬化酒精性肝病(NCA)患者。AC组和NCA组各有一半患者有或无血清HBV标志物。HCC组中抗-HCV抗体的流行率(58.2%)显著高于其他组(AC组为35.9%;NCA组为17.7%)。AC组和NCA组合并后,酒精性肝病患者中抗-HCV流行率为25.8%。总体而言,抗-HCV抗体在HBV阳性患者中比在HBV阴性患者中更常见(42.2%对26.1%,p<0.01),不过单独分析HCC组时差异不显著。抗-HCV阳性样本的S/N比值根据疾病类型(肿瘤性与非肿瘤性)及血清HBV状态而有所不同。实际上,65.6%的HCC患者S/N大于4,而AC组和NCA组分别仅为32.2%和23.5%(p<0.01)。另一方面,超过一半的AC组和NCA组患者S/N小于2,表明某些情况下可能存在假象。即使在HCC组中,15例HBsAg和抗-HCV阳性患者的平均S/N也显著低于仅显示抗-HBV抗体的患者。(摘要截选至250字)